QIAGEN Gross Margin 2006-2021 | QGEN

Current and historical gross margin for QIAGEN (QGEN) over the last 10 years. The current gross profit margin for QIAGEN as of September 30, 2021 is %.
QIAGEN Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2021-09-30 $2.24B $1.45B 64.73%
2021-06-30 $2.19B $1.43B 65.51%
2021-03-31 $2.07B $1.36B 65.86%
2020-12-31 $1.87B $1.23B 65.94%
2020-09-30 $1.71B $1.14B 66.59%
2020-06-30 $1.61B $1.07B 66.67%
2020-03-31 $1.55B $1.03B 66.13%
2019-12-31 $1.53B $1.01B 65.88%
2019-09-30 $1.52B $0.99B 65.33%
2019-06-30 $1.51B $0.99B 65.67%
2019-03-31 $1.51B $1.00B 66.42%
2018-12-31 $1.50B $1.00B 66.71%
2018-09-30 $1.50B $1.00B 66.71%
2018-06-30 $1.48B $0.98B 66.26%
2018-03-31 $1.45B $0.95B 65.54%
2017-12-31 $1.42B $0.92B 65.09%
2017-09-30 $1.39B $0.89B 64.12%
2017-06-30 $1.36B $0.87B 63.83%
2017-03-31 $1.35B $0.86B 63.50%
2016-12-31 $1.34B $0.85B 63.15%
2016-09-30 $1.32B $0.84B 63.71%
2016-06-30 $1.30B $0.83B 63.66%
2016-03-31 $1.28B $0.82B 63.62%
2015-12-31 $1.28B $0.83B 64.64%
2015-09-30 $1.29B $0.82B 63.47%
2015-06-30 $1.31B $0.84B 63.82%
2015-03-31 $1.33B $0.85B 64.38%
2014-12-31 $1.34B $0.87B 64.36%
2014-09-30 $1.35B $0.89B 65.80%
2014-06-30 $1.33B $0.87B 65.59%
2014-03-31 $1.32B $0.83B 62.81%
2013-12-31 $1.30B $0.82B 62.67%
2013-09-30 $1.29B $0.81B 63.12%
2013-06-30 $1.27B $0.80B 63.07%
2013-03-31 $1.26B $0.84B 66.16%
2012-12-31 $1.25B $0.82B 65.71%
2012-09-30 $1.24B $0.79B 63.90%
2012-06-30 $1.23B $0.78B 63.78%
2012-03-31 $1.20B $0.77B 63.86%
2011-12-31 $1.17B $0.75B 64.16%
2011-09-30 $1.12B $0.74B 65.74%
2011-06-30 $1.11B $0.73B 66.00%
2011-03-31 $1.09B $0.72B 65.78%
2010-12-31 $1.09B $0.72B 65.87%
2010-09-30 $1.09B $0.72B 65.60%
2010-06-30 $1.08B $0.71B 65.71%
2010-03-31 $1.05B $0.69B 65.91%
2009-12-31 $1.01B $0.67B 66.04%
2009-09-30 $0.96B $0.64B 66.39%
2009-06-30 $0.93B $0.62B 66.31%
2009-03-31 $0.91B $0.60B 66.59%
2008-12-31 $0.89B $0.60B 67.08%
2008-09-30 $0.87B $0.58B 66.63%
2008-06-30 $0.81B $0.54B 66.50%
2008-03-31 $0.73B $0.49B 66.53%
2007-12-31 $0.65B $0.43B 66.62%
2007-09-30 $0.57B $0.42B 74.91%
2007-06-30 $0.51B $0.39B 76.92%
2007-03-31 $0.49B $0.41B 84.54%
2006-12-31 $0.47B $0.43B 92.27%
2006-09-30 $0.44B $0.38B 85.36%
2006-06-30 $0.43B $0.37B 86.12%
2006-03-31 $0.41B $0.32B 77.67%
2005-12-31 $0.40B $0.28B 69.10%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.791B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88